Skip to main content

Table 4 Multivariate analysis of risk factors for the development of IE amongst patients with GBS bacteremia

From: Streptococcus agalactiae infective endocarditis in Canada: a multicenter retrospective nested case control analysis

Risk factor

OR

95% CI

p value

Injection drug use

19.6

3.39–111.11

0.001

Prosthetic valve

11.5

1.73–76.92

0.011

Recurrent bacteremia

0

N/A

0.99

Source identified

0.26

0.085–0.80

0.019